Gillison ML, Ferris RL, Harris J, Colevas AD, et al. Safety of nivolumab added to chemoradiotherapy platforms for intermediate and high-risk local-regionally advanced head and neck squamous cell carcinoma: RTOG Foundation 3504. Int J Radiat Oncol Biol Phys 2022 Oct 10. pii: S0360-3016(22)03434.
PMID: 36228746